BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms. (2014)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2013.234
PubMed Identifier: 23929215
Publication URI: http://europepmc.org/abstract/MED/23929215
Type: Journal Article/Review
Volume: 28
Parent Publication: Leukemia
Issue: 1
ISSN: 0887-6924